THE EFFICACY OF SWITCHING FROM OTHER BASAL INSULIN TO INSULIN DEGLUDEC AMONG PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES ON INTENSIVE INSULIN THERAPY

被引：0
|
作者：
Kakizaki, Y. [1 ]
Sasaki, J. [1 ]
Sakakura, K. [2 ]
Tamaru, S. [1 ]
Shikuma, J. [1 ]
Ito, R. [1 ]
Miwa, T. [1 ]
Odawara, M. [1 ]
机构：
[1] Tokyo Med Univ, Dept Diabet Endcrinol & Metab, Tokyo 1608402, Japan
[2] Tokyo Med Univ, Dept Pharm, Tokyo 1608402, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70552-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO258
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [41] Comparison of the efficacy and safety of insulin degludec between type 1 and type 2 diabetes
    Fujiya, Atsushi
    Shimauchi, Risa
    Kato, Makoto
    Miura, Emiri
    Shibata, Taiga
    Sobajima, Hiroshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S128 - S128
  • [42] Basal insulin therapy in type 2 diabetes
    Bethel, MA
    Feinglos, MN
    JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2005, 18 (03): : 199 - 204
  • [43] Evaluation of insulin degludec as baseline insulin therapy in children and adolescents with type 1 diabetes
    Sellbom, Malin
    Nilsson, Charlotta
    PRACTICAL DIABETES, 2021, 38 (02) : 13 - 19
  • [44] Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
    Blak, B. T.
    Smith, H. T.
    Hards, M.
    Curtis, B. H.
    Ivanyi, T.
    DIABETIC MEDICINE, 2012, 29 (07) : E13 - E20
  • [45] Insulin degludec: a novel ultra-long-acting basal insulin for use in Type 1 and 2 diabetes
    Meneghini, Luigi F.
    Miranda-Palma, Bresta
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 9 - 14
  • [46] Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
    Wu, Yiming
    Zhang, Junqing
    Li, Ang
    DIABETES THERAPY, 2024, 15 (12) : 2515 - 2523
  • [47] Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
    Cho, Kyu Yong
    Nakamura, Akinobu
    Oba-Yamamoto, Chiho
    Tsuchida, Kazuhisa
    Yanagiya, Shingo
    Manda, Naoki
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES & METABOLISM JOURNAL, 2020, 44 (04) : 532 - +
  • [48] Usefulness of Insulin Degludec in Older Patients with Type 2 Diabetes Poorly Controlled by Previous Insulin Therapy
    Yoshida, Mami
    Oh, Eriko
    Kimata, Hiroe
    Yamamoto, Naomune
    Saeki, Akio
    Sugino, Masakazu
    Yoshida, Shigeru
    Kuzuya, Takeshi
    Ohsawa, Nakaaki
    Sano, Hiroyuki
    Hanafusa, Toshiaki
    DIABETES, 2016, 65 : A247 - A247
  • [49] Intensifying Insulin Therapy with Insulin Analog Premixes: Transitioning from Basal Insulin in Type 2 Diabetes
    Shanik, Michael H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (06) : 533 - 539
  • [50] Effectiveness of insulin degludec in Type 1 diabetes
    Dar, S.
    Brewer, D.
    Karamat, M. A.
    DIABETIC MEDICINE, 2015, 32 : 108 - 109
12345